News
2021 Updates: Lilly's Global COVID-19 Response
View Story
Living With Osteoarthritis: The Importance of Being Heard
View Story
Your COVID-19 Treatment Journey: Our Antibodies Might Help
View Story
'A Day On – Not a Day Off': Honoring Dr. Martin Luther King Jr.’s Legacy
View Story
2020 Updates: Lilly's Global COVID-19 Response
View Story
Time to Tear Down the Rebate Wall
View Story
INDIANAPOLIS , Jan. 22, 2021 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) today announced the successful completion of its acquisition of Prevail Therapeutics Inc. (NASDAQ: PRVL). The acquisition establishes a new modality for drug discovery and development at Lilly , extending Lilly 's
January 21, 2021
Tags | Product
INDIANAPOLIS , Jan. 21, 2021 /PRNewswire/ -- Bamlanivimab (LY-CoV555) significantly reduced the risk of contracting symptomatic COVID-19 among residents and staff of long-term care facilities, Eli Lilly and Company (NYSE: LLY) announced. The Phase 3 BLAZE-2 COVID-19 prevention trial – conducted in
January 19, 2021
Tags | Corporate
INDIANAPOLIS and UTRECHT, The Netherlands , Jan. 19, 2021 /PRNewswire/ -- Loxo Oncology at Lilly , a research and development group of Eli Lilly and Company (NYSE: LLY), and Merus N.V. (NASDAQ: MRUS), a clinical-stage oncology company developing multi-specific antibodies, today announced a research
January 15, 2021
Tags | Financial
INDIANAPOLIS , Jan. 15, 2021 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its fourth-quarter and full-year 2020 financial results on Friday, January 29, 2021 . Lilly will also conduct a conference call on that day with the investment community and media to further detail the